Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 25;11(8):3624–3641. doi: 10.7150/thno.51795

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Participation of TREM1 in breast cancers. A, mRNA levels of TREM1 were measured in indicated cells by real-time PCR. B, Immunoblotting assays for TREM1 and GAPDH in indicated cells. C, Expression levels of TREM1 in breast carcinoma (n = 1102) and normal (n = 113) tissue in TCGA-BRCA cohort. D, Expression levels of TREM1 in different breast cancer subtypes in TCGA-BRCA cohort. Number of samples in each subtype is indicated at the bottom. E, Representative IHC staining of TREM1 signal in different breast cancer subtypes and normal tissue. Scale bar, 100 µm in the original region and 25 µm in the zoomed-in region respectively. F, Intensity of TREM1 signals was quantified as Quick score (Q). G, Kaplan-Meier analysis of overall survival (OS), metastasis-free survival (MFS), and relapse-free survival (RFS) curves of patients with breast cancer (GSE7390; n = 198) stratified by TREM1 expression.